$5.2 Billion Cell and Gene Therapy Market to Grow Tenfold from 2021-2031

ARLINGTON, Va., March 7, 2022 /PRNewswire/ -- It is an exciting and interesting time for companies involved in cell and gene therapy as the industry is forecast to grow tenfold between 2021 to 2031, according to leading medical market research firm Kalorama Information in Cell Therapy And Gene Therapy Markets, one of two new reports published on the topic.

Currently, the global cell and gene therapy market is worth an estimated $5,193 million ($5.2 billion) as of 2021.

"Kalorama anticipates sales from oncology, cardiovascular-blood and genetic conditions will be key contributors to the cell and gene therapy market's strong performance going forward," says Bruce Carlson, publisher for Kalorama Information.

Cell and gene therapy offers promising treatments for many acquired diseases such as cancer, diabetes, Parkinson's disease and genetic diseases to correct defective genetic material. The science is moving ahead and now the industry needs to industrialize and standardize the manufacturing and commercialization of products. The industry is moving in the direction of a standardized set-up and a closed automated system.

Consequently, cell and gene therapy products are transforming the treatment of cancers and genetic diseases. Additionally, cell and gene therapies are expanding into other areas of medicine including autoimmune diseases, cardiovascular diseases, musculoskeletal disease, dermatological diseases and many others.

For more insights and data from Cell Therapy And Gene Therapy Markets, purchase the report at: https://kaloramainformation.com/product/cell-gene-therapy-world-market/. 

Also available is Kalorama Information's companion report, Cell and Gene Therapy Deals: Financings, Partnering, M&A, Technology Transfers, IPOs, and Other Developments, which be purchased at: https://kaloramainformation.com/product/cell-and-gene-therapy-deals-analysis/.

In addition, Kalorama publishes a twice-monthly newsletter on this market, Cell and Gene Therapy Business Outlook. To subscribe visit: https://kaloramainformation.com/cell-and-gene-therapy-business-outlook/

About Kalorama Information
Kalorama Information, part of Science and Medicine Group, is the leading publisher of market research in healthcare areas, including in vitro diagnostics (IVD), biotechnology, medical devices, and pharmaceuticals. Science and Medicine Group supports companies seeking to commercialize the rapidly changing marketplace at the intersection of science, medicine, and technology. Comprised of industry-leading brands, Science and Medicine Group serves analytical instrument, life science, imaging, and clinical diagnostic companies by helping them create strategies and products to win markets and provide platforms to digitally engage their markets through a variety of innovative solutions. Kalorama Information produces 30 reports a year. The firm offers a Knowledge Center, which provides access to all published reports.

SOURCE Kalorama Information